Wiskott-Aldrich syndrome (WAS) is an X-linked primary immunodeficiency disorder associated with microthrombocytopenia, eczema, autoimmunity and predisposition to malignant lymphoma. Although rare, few cases of somatic mosaicism have been published in WAS patients to date. We here report on two Ukrainian siblings who were referred to us at the age of 3 and 4 years, respectively. Both patients suffered from severe WAS caused by a nonsense mutation in exon 1 of the WAS gene. In both siblings, flow cytometric analysis revealed the presence of WASp-positive and WASp-negative cell populations amongst T and B lymphocytes as well as NK cells. In contrast to previously described cases of revertant mosaisicm in WAS, molecular analyses in both children showed that the WASp-positive T cells, B cells, and NK cells carried multiple different second-site mutations, resulting in different missense mutations. To our knowledge, this is the first report describing somatic mosaicism in WAS patients caused by several independent second-site mutations in the WAS gene.
WASp deficiency causes multiple cellular defects, including defective leukocyte migration, defective T cell proliferation and disturbed formation of the immunological synapse (2, 3).
Several cases of revertant mosaicism have been described for WAS (4) (5) (6) (7) (8) (9) . The observation that the genetic reversion in a single or few cells can give rise to somatic mosaicism supports the concept that WASp expression confers a selective advantage at least for T lymphocytes and NK cells, which has important implications for the prospect of gene therapy approaches for this disorder (10).
We here report on two 3-and 4-year old siblings suffering from WAS with a novel nonsense mutation in exon 1 of the WAS gene, in both of whom somatic mosaicism for WASp was observed. Molecular investigations provided evidence for several independent second-site mutations in both patients. This observation adds to the growing understanding of somatic mosaicism in WAS. 
Materials and Methods

Patients and controls
All material from patients and healthy donors was obtained with informed assent/consent in accordance with the Declaration of Helsinki.
Flow cytometry
Immunophenotyping and flow cytometric analysis of WASp expression in peripheral blood mononuclear cells (PBMCs) were performed as described previously (9, 11) .
T cell proliferation assays
T cell proliferation assays were performed as described previously with minor modifications (12) . In brief, T cell stimulation was performed using anti-CD3 coated 96 well plates with or without additional human IL-2 at a final concentration of 10 IU/ml. Cells were stimulated for 48 hours before pulsing with 1µCi (0.037 MBq) of 3 H-Thymidine (Perkin Elmer, Jügesheim, Germany) for 24 hours and subsequent analysis of thymidine incorporation.
Podosome staining
CD14+ cells were labelled with anti-CD14 magnetic beads (Milteny Biotech, Bergisch Gladbach, Germany) and isolated using an AutoMACS device (Milteny Biotech). Podosome analysis was performed as described previously (13) . To demonstrate the presence of several independent second-site mutations, exon 1 of the WAS gene in the WASp-positive and WASp-negative CD3+ lymphocyte, the WASP-positive CD3-CD56+ NK cell fraction and B cell population (sorted as CD3-CD56-CD19+CD20+ cells) was amplified using the primer pair described above. The product was gel extracted and subcloned into PCR Script cloning vector (Stratagene, Amsterdam, Netherlands). Sequencing of clones was performed using M13 universal primers. We performed T cell proliferation assays in both patients and found decreased proliferative responses upon CD3 stimulation, which could be partially rescued by additional stimulation with hIL-2 ( Fig. 1a) . Furthermore, we performed podosome analysis in peripheral blood CD14+ monocytes and found complete absence of podosomes in both patients, while a healthy control displayed 65% podosome-positive monocytes (Fig. 1b) . Both patients had less than 50,000 platelets/microliter (Table 1) . Immunophenotyping revealed decreased numbers of B lymphocytes in both patients as well as inverted CD4-CD8 ratios (Table 1 ). IgG levels in both patients were within the normal range. Specific antibodies to vaccines were dissociated.
Molecular analysis
Patient 1 mounted a protective response to tetanus (0.11 IU/ml) but not to diptheria (0.08 IU/ml). Patient 2 had 0.15 IU/ml anti-tetanus-IgG and 0.18 IU/ml anti-diptheria IgG.
Flow cytometric analysis of WASp expression in peripheral blood mononuclear cells was performed and revealed the presence of fractions of WASp-positive and WASp-negative cells amongst CD3+ lymphocytes and NK cells in both patients (Fig. 2) . In both patients, the majority of CD8+ lymphocytes and NK cells were WASP-positive. A fraction of 31% of CD4+ lymphocytes were positive in the elder brother (patient 1), whereas only a minor fraction of 4% of CD4+ cells were positive in the younger brother (patient 2). A small fraction of B lymphocytes from both patients were also WASp-positive, whereas no WASPpositive cells were identified in monocytes (Fig. 2) .
We next performed flow cytometric sorting of WASp-positive and WASp-negative CD3+
lymphocytes from both patients, extracted DNA and sequenced all 12 exons of the WAS gene. The WASp-negative cell fraction harboured a novel mutation in exon 1, leading to a premature stop codon (c.C58T; p.Q20X). In contrast, analysis of the WASp-positive cell fraction showed an ambiguous signal for nucleotides 2 and 3 of the triplet of interest (Fig. 3) .
Thus, our findings suggested that the WASp+ CD3+ lymphocytes contained cells with different second-site mutations within the same triplet. The chromatograms showed that, for the WASp+ cell fraction, the "dominant" triplet was TAT in patient 1 and TGG in patient 2 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Fig. 3) . 1 out of 52 clones contained the original mutation TAG, thus representing missorted cells.
In contrast to WASp+ CD3+ cells, the chromatograms for WASp+ NK cells suggested the presence of a predominant TGG triplet for both patients. We found that 19 out of 20 clones from patient 1 contained the TGG sequence, while one clone contained the triplet TAC. For patient 2, 10 clones were analyzed, all of which contained the triplet TGG. Since also a minor B cell population appeared to be reverted in both patients (Fig. 2) , we also sorted CD3-CD56- However, immunophenotypic analysis showed that both patients had persistent B cell lymphopenia. The CD4-CD8 ratio remained inverted (Table 1) . An open question is whether the altered WAS protein is indeed functional. We have attempted to express the altered WAS protein in a retroviral vector system but could not achieve sufficient protein expression levels. Longitudinal observation of these patients suggests that they may have a clinical benefit from the second-site mutations, with an overall decreased bleeding diathesis and eczema in both patients. Of note, their platelet counts normalized.
However, these observations remain anecdotal. In a clinical perspective, it remains difficult to define parameters guiding rational therapeutic decisions in WAS patients showing spontaneous somatic chimerism. Should allogeneic bone marrow transplantation or experimental gene therapy be performed in these patients? In view of the inherent difficulty in judging the consequences of retrovirus-mediated WASp expression, we decided not to offer experimental gene therapy at the present time.
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